"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.
about
The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseasesEpicardial Fat: Physiological, Pathological, and Therapeutic ImplicationsNovel phenotypes of prediabetes?Thermogenic potential and physiological relevance of human epicardial adipose tissueNew obesity classification criteria as a tool for bariatric surgery indicationEpicardial fat: definition, measurements and systematic review of main outcomesCardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular diseaseEctopic fat assessment focusing on cardiometabolic and renal riskHuman obesity and endothelium-dependent responsivenessThe endocrine function of adipose tissue: an updateExercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.Muscle microvasculature's structural and functional specializations facilitate muscle metabolism.STAT4 contributes to adipose tissue inflammation and atherosclerosis.Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle.Insulin-induced changes in skeletal muscle microvascular perfusion are dependent upon perivascular adipose tissue in womenCrosstalk between perivascular adipose tissue and blood vessels.Meal-related increases in microvascular vasomotion are impaired in obese individuals: a potential mechanism in the pathogenesis of obesity-related insulin resistance.Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart StudyClinical importance of epicardial adipose tissue.Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009.Links between ectopic fat and vascular disease in humansAndroid fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly peoplePericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study.Inflammation markers are associated with cardiovascular diseases risk in adolescents: the Young Hearts project 2000Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders.Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations.Muscle as a secretory organ.Periaortic fat deposition is associated with peripheral arterial disease: the Framingham heart studyPerivascular adipose tissue and its role in type 2 diabetes and cardiovascular diseaseVisceral and subcutaneous adiposity and brachial artery vasodilator function.Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.Perivascular adipose tissue and vascular diseaseChemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for local chemerin in atherosclerosis?Indoleamine 2,3-diooxygenase in periaortic fat: mechanisms of inhibition of contractionSimilarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation.Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice.Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target.A Longitudinal Study of Association between Adiposity Markers and Intraocular Pressure: The Kangbuk Samsung Health StudyThe impact of obesity on the relationship between epicardial adipose tissue, left ventricular mass and coronary microvascular function.
P2860
Q21296864-C3FB912A-F69E-40A6-A027-87A2903EBB6CQ26746996-DFC0530E-ED96-4F6A-8CC9-41AFB4EB61D7Q26747128-DA2FE9C0-26F9-43F2-95E1-1687B85C361DQ26751868-79AE0398-A972-4165-8EAE-6D39BE12691BQ26774656-21C00EAF-80E5-40A4-8CCA-A6232DB3318CQ26823115-C374622F-8197-415B-AF45-9C9C47AE8480Q26991652-124F7367-A808-408E-BAF3-B0572EFE7E0BQ27015940-C58E15FF-C996-4992-A287-288E620B9E32Q27021665-BD8F2F98-572D-4B7F-8A49-3DD5951B437EQ28305131-FF5626A8-32C6-4D78-915C-6E4781739A4EQ30238666-DEE1BF1D-950C-44C3-93BE-F3E55858CAC3Q30277845-807C3F41-12BC-4B56-947B-40C514B9B745Q30357364-A28C02A7-642F-40AA-A9CE-07A363CC8B7FQ30438252-B776359F-2028-498F-9ABE-96988BBE843DQ30657461-906CF354-8381-4633-BC08-617FA4106B59Q33746394-1C78A3BA-661E-4F3C-9FA5-4B67BFD877FEQ33883164-008D5D01-51F0-48F9-A0C4-5805A27A42CCQ33886754-063C014D-A27E-494E-9A47-0AD308901D35Q33897351-2CBAC820-BFA5-46E8-B329-8BFDE22C5F36Q34016157-F54A7538-449F-463D-BFD8-AC83B7D7E2B8Q34076155-EFE9AC53-D321-43C7-AE2E-8A5E12BDD187Q34078019-24EDF012-9879-4F76-858F-542FFDCBF0E4Q34193392-1BD5281C-8D90-41B5-AE40-2AB150A7BF93Q34218116-3F51D051-30A7-4D98-8659-1DD4C5F64C42Q34244082-453411F3-FD0F-401D-8B5E-51B7A78A56C9Q34297183-742BEA1E-8A85-4B59-86C3-4901D5C04EFEQ34360586-80281BF8-6385-4D26-AE5F-5F4079A61E6FQ34692220-ECD7CE28-D205-480B-8143-EB80986243F6Q34902082-00A3FDAB-DB9B-45B9-8037-7C6B66560161Q34914900-67CFD503-77E1-4E9A-A668-C36D2C3D7464Q34988107-0B35D444-12A6-45B3-9D32-E110922D940CQ35047205-130BE51F-AE62-4AF1-A162-3697932D8806Q35159362-5F6F026E-52D7-41BC-A875-78219FEE30EEQ35395398-5DB73AFF-C096-4565-9BE4-2AA8DA6C1760Q35395679-14EF50E5-D950-4F1F-B455-0C22A7023734Q35501257-1B55BA92-6659-439C-AC96-449E8983ABC5Q35859743-8445595B-D7DF-4812-B1C3-211823C79292Q35859762-B85C13D6-851D-4AFC-A854-9657CA8C552BQ35885636-9A7A44A8-7B8A-4D83-84A8-F85FF7502988Q35905541-BDC6AAC8-C527-47C2-9AD5-EF07738D40B7
P2860
"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
"Vasocrine" signalling from pe ...... esistance to vascular disease.
@en
"Vasocrine" signalling from pe ...... esistance to vascular disease.
@nl
type
label
"Vasocrine" signalling from pe ...... esistance to vascular disease.
@en
"Vasocrine" signalling from pe ...... esistance to vascular disease.
@nl
prefLabel
"Vasocrine" signalling from pe ...... esistance to vascular disease.
@en
"Vasocrine" signalling from pe ...... esistance to vascular disease.
@nl
P1433
P1476
"Vasocrine" signalling from pe ...... esistance to vascular disease.
@en
P2093
Etto Eringa
John S Yudkin
P304
P356
10.1016/S0140-6736(05)66585-3
P407
P577
2005-05-01T00:00:00Z